Noémie Elhadad, Ph.D.
Chair and Associate Professor, Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University; Director of Medical Information Services, NewYork-Presbyterian Hospital

Dr. Elhadad is Chair and Associate Professor of the Department of Biomedical Informatics at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and Director of Medical Information Services at NewYork-Presbyterian Hospital. She leads the AI at VP&S Initiative and Eve_n, Columbia University’s research initiative on data-powered women’s health. Her research sits at the intersection of artificial intelligence (AI), human-centered computing, and medicine, with a focus on developing novel machine-learning methods. She designs AI-driven tools to support patients and clinicians, ensuring that the AI systems of the future are safe and effective and advance medicine. 

Kjiersten Fagnan, Ph.D.
Chief Informatics Officer, U.S. Department of Energy Joint Genome Institute, Lawrence Berkeley National Laboratory

Dr. Fagnan joined the U.S. Department of Energy (DOE) Joint Genome Institute (JGI) in 2012 as a National Energy Research Scientific Computing (NERSC) bioinformatics computing consultant, after completing a petascale postdoctoral fellowship at NERSC and the Lawrence Berkeley National Laboratory Computational Research Division. As a postdoc, her research focused on stable and accurate computational methods for reacting subsurface flows and evolved into scalable methods for scientific data analysis. In 2014 Dr. Fagnan became the Engagement Lead for JGI with a focus on adapting JGI workloads to run on supercomputing hardware and worked closely with staff to understand the data-intensive nature of JGI workloads. Dr. Fagnan was appointed Chief Informatics Officer of JGI in 2016 and then Head of its Data Science and Informatics Department in 2018. Also in 2018, Dr. Fagnan was part of the Gordon Bell prize–winning team at the Supercomputing conference, SC’18, led by researchers at Oak Ridge National Laboratory. Dr. Fagnan has been the Distinguished Speaker at IBM Research in Almaden where she presented work related to distributed data and workflow management. Dr. Fagnan is currently leading a bio-eco data integration effort to develop a global search for five DOE-funded resources. 

Nicole K. Kleinstreuer, Ph.D.
Acting Deputy Director for Program Coordination, Planning, and Strategic Initiatives; Acting Director, Division of Program Coordination, Planning, and Strategic Initiatives, NIH

Dr. Kleinstreuer is the Acting NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives. In this role, she leads the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) within the NIH Office of the Director, which oversees NIH-wide programmatic research and strategic policy initiatives, including the NIH Common Fund and offices focused on women’s health, data science, AIDS research, disease prevention, behavioral and social sciences, dietary supplements, and tribal health, among others. 

Dr. Kleinstreuer is internationally recognized for her leadership in developing innovative, human-relevant research strategies that advance public health protection. Prior to her current position, she served as Director of the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods within the National Institute of Environmental Health Sciences (NIEHS). She also served as Executive Director of the congressionally mandated Interagency Coordinating Committee on the Validation of Alternative Methods and as the U.S. National Co-Coordinator for the Organization for Economic Cooperation and Development Test Guidelines Programme. In these roles, she led interagency and international efforts to promote new approach methodologies, reduce animal testing, and integrate computational modeling, artificial intelligence, and systems toxicology into regulatory science. Her work spans translational bioinformatics, predictive modeling, and quantitative risk assessment. She has authored more than 150 peer-reviewed publications and received numerous honors, including the 2019 Society of Toxicology Achievement Award, the 2025 Enhancement of Animal Welfare Award, and  multiple NIH Director’s and NIEHS Merit Awards. 

Dr. Kleinstreuer holds B.S. degrees in biomedical engineering and applied mathematics from the University of North Carolina (UNC) at Chapel Hill and a Ph.D. in bioengineering from the University of Canterbury. She completed postdoctoral training in computational toxicology at the U.S. Environmental Protection Agency and holds adjunct faculty appointments at Yale University and UNC Chapel Hill. She is deeply committed to mentorship, public health protection, and scientific innovation that enhances the translation of biomedical research to real-world impact. 

Jason H. Moore, Ph.D., FACMI, FIAHSI, FASA
Chair, Department of Computational Medicine and Director, Center for Artificial Intelligence Research and Education, Cedars-Sinai Medical Center; Editor-in-Chief, BioData Mining

Dr. Moore is Chair of the Department of Computational Medicine at Cedars-Sinai Medical Center where he serves as Director of the Center for Artificial Intelligence Research and Education. He leads an active research program focused on the development and application of artificial intelligence (AI) algorithms for the analysis of biomedical data. Recent work focuses on methods for automated machine learning (AutoML) with a goal of democratizing AI in health care. He is an elected fellow of the American College of Medical Informatics, the International Academy of Health Sciences Informatics, and the American Statistical Association. He is Editor-in-Chief of the journal BioData Mining. 

Dina N. Paltoo, Ph.D., M.P.H.
Acting Deputy Director of Policy and External Affairs, National Library of Medicine, NIH

Dr. Paltoo is the Acting Deputy Director of Policy and External Affairs at the NIH National Library of Medicine (NLM). In this role, she is a Senior Advisor to the NLM Director; establishes and implements policy frameworks that guide NLM’s research, operations, and public services; and works alongside NLM’s Deputy Director for Operations and Innovation. She also oversees NLM’s relationships across NIH and with external groups. Dr. Paltoo was recently the Assistant Director, Scientific Strategy and Innovation in the Immediate Office of the Director  of the National Heart, Lung, and Blood Institute (NHLBI), where she served as a Senior Advisor to the NHLBI Director and provided leadership and strategic direction to complex scientific initiatives and programs related to the NHLBI mission. 

Dr. Paltoo previously served as the Assistant Director for Policy Development at NLM and led NLM’s policy and legislative activities that promoted responsible stewardship and access to scientific and clinical data and information, as well as health information technology. Before joining NLM, Dr. Paltoo was the Director of the Division of Scientific Data Sharing Policy and the Director of the Genetics, Health, and Society Program within the NIH Director’s Office of Science Policy and was responsible for NIH policy efforts and ethical considerations in scientific data sharing and management, open science, and genomics and health. Dr. Paltoo has also served as a Program Director at NHLBI, where she maintained a scientific portfolio in genetics, pharmacogenetics, and personalized medicine. In her various roles at NIH, she has partnered across NIH, the Department of Health and Human Services, federal agencies, and various organizations on initiatives and activities relevant to open science, data science, and public access. 

Dr. Paltoo received her B.S. in microbiology and Ph.D. in physiology and biophysics from Howard University, M.P.H. from the Johns Hopkins Bloomberg School of Public Health, and Certificate in Public Leadership from Washington University Olin Business School at The Brookings Institution. She was a postdoctoral fellow in cellular biophysics and biochemistry at the University of Medicine and Dentistry of New Jersey and is an alumna of the Cancer Prevention Fellowship Program at the National Cancer Institute, where her research focus was molecular epidemiology.